Product Development Partnership

A product development partnership (PDP) is a collaborative model for developing technologies — particularly drugs, vaccines, and diagnostics — in which public institutions, private companies, academic researchers, and philanthropic organizations share costs, risks, and intellectual property. PDPs are designed to address market failures in which the social value of a technology exceeds its commercial value, making conventional private-sector development economically unviable.

The PDP model emerged in the late 1990s and early 2000s as a response to the 10/90 gap in health research. Organizations such as the Drugs for Neglected Diseases initiative and the Medicines Patent Pool operate as PDPs, coordinating distributed research capacity without owning the full vertical stack of development. The model is a form of distributed cognition applied to industrial innovation: the knowledge and capacity are distributed across institutions, and the coordination function is performed by a central entity that manages the feedback topology of the collaboration.